In Hypertension (high blood pressure) Nyfe-SA 2.5mg/2.5mg Tablet is a combination medicine that contains two active ingredients, S-Amlodipine and Nebivolol. Both of the medicines in this combination work to lower blood pressure but in different ways. Together they help to relax blood vessels, reduce heart rate and make it easier for your heart to pump blood around your body. This lowers blood pressure. If your blood pressure is controlled you are less at risk of having a heart attack, stroke or kidney problems. The medicine must be taken regularly as prescribed to be effective. You do not usually feel any direct benefit from taking this medicine, but it works in the long term to keep you well. You should also make appropriate lifestyle changes (such as eating healthy and staying active) to maximize the effectiveness of this medicine.
It is unsafe to consume alcohol with Nyfe
Pregnancy : CONSULT YOUR DOCTOR
SA 2.5mg/2.5mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Nyfe
Driving : UNSAFE
SA 2.5mg/2.5mg Tablet may cause side effects which could affect your ability to drive. As patients taking Nyfe
Kidney : CAUTION
SA 2.5mg/2.5mg Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Nyfe
Liver : CAUTION
SA 2.5mg/2.5mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Nyfe
If you miss a dose of Nyfe-SA 2.5mg/2.5mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More